Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Healthy Adult Participants 1

Interventions

pembrolizumab 259Cyclophosphamide 242Specimen Handling 199fludarabine 174Magnetic Resonance Spectroscopy 174Biopsy 148Nivolumab 119Carboplatin 98Radiotherapy 92Paclitaxel 84venetoclax 82Cisplatin 81fludarabine phosphate 79Gemcitabine 79Injections 69Ipilimumab 63Dexamethasone 61atezolizumab 59Bevacizumab 59Cetuximab 57Azacitidine 56Radiation 55Fluorouracil 55durvalumab 54Radiosurgery 52Temozolomide 47Rituximab 44Oxaliplatin 44Irinotecan 43Docetaxel 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Flurbiprofen × 1 year × Clear all
NCT07235748 2026-02-17

Drug-drug Interaction Study of Vorasidenib With Bupropion, Repaglinide, Flurbiprofen, Omeprazole, Midazolam, and Rosuvastatin in Healthy Adult Participants

Servier

Phase 1 Completed
28 enrolled

Healthy Adult Participants

Data powered by HemOnc (CC BY 4.0) Colophon âš¡